Answers are grounded in this paper and cite their sources.
Leukotrienes may be considered asthmatic mediators. Compounds inhibiting their production and activity show promise in the treatment of asthma. Further clinical studies will determine the clinical usefulness of such agents.
No takes yet. Share an insight, caveat, or question.
Jeffrey M. Drazen (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: